Cargando…

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer

BACKGROUND: The treatment efficacy of immune checkpoint inhibitor (ICI) and clinical outcomes in patients with non‐small cell lung cancer (NSCLC) who develop severe grade checkpoint inhibitor pneumonitis (CIP) are unclear. Here, we report on the treatment efficacy of ICI and prognosis in NSCLC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tone, Mari, Izumo, Takehiro, Awano, Nobuyasu, Kuse, Naoyuki, Inomata, Minoru, Jo, Tatsunori, Yoshimura, Hanako, Minami, Jonsu, Takada, Kohei, Miyamoto, Shingo, Kunitoh, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775002/ https://www.ncbi.nlm.nih.gov/pubmed/31482678 http://dx.doi.org/10.1111/1759-7714.13187

Ejemplares similares

Treatment effect and safety profile of salvage chemotherapy following immune checkpoint inhibitors in lung cancer
por: Tone, Mari, et al.
Publicado: (2019)

Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective study
por: Izumo, Takehiro, et al.
Publicado: (2020)

Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia
por: Izumo, Takehiro, et al.
Publicado: (2020)

Usefulness of Measurement of End-tidal CO(2) Using a Portable Capnometer in Patients with Chronic Respiratory Failure Receiving Long-term Oxygen Therapy
por: Jo, Tatsunori, et al.
Publicado: (2020)

Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound‐guided transbronchial needle aspiration samples for next‐generation sequencing analysis
por: Tone, Mari, et al.
Publicado: (2020)

Efficacy and safety of semi-flexible thoracoscopic cryobiopsy in the diagnosis of elderly tuberculous pleurisy
por: Jo, Tatsunori, et al.
Publicado: (2020)

Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma
por: Akagi, Yu, et al.
Publicado: (2020)

Prospective multicentre study on the safety and utility of transbronchial lung cryobiopsy with endobronchial balloon
por: Inomata, Minoru, et al.
Publicado: (2020)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Rapid effects of benralizumab on severe asthma during surgery for residual tumor after advanced lung squamous cell carcinoma treatment with pembrolizumab
por: Izumo, Takehiro, et al.
Publicado: (2019)

The combination of EBUS-TBNA and the PAB antibody led to a successful treatment for lung cancer in a patient with asymptomatic sarcoidosis mimicking nodal metastasis
por: Tone, Mari, et al.
Publicado: (2018)

The 2014 autochthonous dengue fever outbreak in Tokyo: A case series study and assessment of the causes and preventive measures
por: Kori, Mayuko, et al.
Publicado: (2020)

Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study
por: Inomata, Minoru, et al.
Publicado: (2021)

A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy
por: Muto, Yutaka, et al.
Publicado: (2021)

Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan
por: Muto, Yutaka, et al.
Publicado: (2021)

Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate
por: Muto, Yutaka, et al.
Publicado: (2021)

An autopsy case of idiopathic pulmonary fibrosis with remarkable honeycomb cyst expansion
por: Ito, Yu, et al.
Publicado: (2022)

Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Awano, Nobuyasu, et al.
Publicado: (2021)

Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Pulmonary amyloidosis diagnosed via transbronchial lung cryobiopsy without surgical lung biopsy: A case series
por: Fujimoto, Kazushi, et al.
Publicado: (2022)

Anxiety, Depression, and Resilience of Healthcare Workers in Japan During the Coronavirus Disease 2019 Outbreak
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports
por: Ito, Yu, et al.
Publicado: (2021)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
por: Lin, Xinqing, et al.
Publicado: (2022)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
por: Wang, Hanping, et al.
Publicado: (2019)

Adult T-cell leukemia/lymphoma complicated by Pneumocystis pneumonia in a non-endemic area
por: Kunimoto, Mayu, et al.
Publicado: (2023)

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
por: Correale, Pierpaolo, et al.
Publicado: (2020)

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
por: Serzan, Michael T, et al.
Publicado: (2020)

Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis
por: Davis Puente, Andrea, et al.
Publicado: (2023)

Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2023)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2022)

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
por: Chuzi, Sarah, et al.
Publicado: (2017)

Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
por: Zhu, Shicong, et al.
Publicado: (2020)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis
por: Ando, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4tq2kl1ok5nb38jqfjogu2a4r